Analysis: Orlistat leads to reduced waist circumference

09/23/2013 | MedPage Today (free registration)

An analysis of multiple studies showed that overweight or obese patients taking orlistat had greater reductions in waist circumference at six and 12 months than did those who took a placebo or had standard care such as lifestyle advice and exercise, U.K. researchers reported on the website of Diabetes, Obesity and Metabolism. Researchers said the use of lorcaserin did not have a significant effect on waist circumference.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI